Anxiety Insights
sponsored by

Endsleigh offer competitive
Life Insurance policies


««
January 2007
»»
S M
T
W T F S
  1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28 29 30 31
Archives
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
Search
 
LinkBlog
  • NIMH sponsored postpartum depression site
  • Acupressure points for relieving anxiety and nervousness
  • The limits of rational thought
  • Full LinkBlog
Blog Board
Name 

(Note: anti spam delay set)
Contact

Mailing List
RSS Feed

 
Translations

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.
anti torture campaign
Hit Counter
Total: 339,576
Last Reset: 04:05, 14 May 06
Login Console

Log-In

My Blog    My Profile

Leave Message

Add as neighbor





Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Bloggapedia - Find It!

6 January 2007
Antidepressant selection gene testing fails to improve patient outcomes
There is insufficient evidence to determine if current gene-based tests intended to personalize the dose of selective serotonin reuptake inhibitors (SSRIs) improve patient outcomes or aid in treatment decisions in the clinical setting
Saturday, 6-Jan-2007 05:29 AM :: Anxiety Insights

Abstract+: The combination of D-Cycloserine and CBT for anxiety disorders
[B]asic research in animal extinction paradigms, has led to intervention studies examining the use of D-cycloserine (DCS) to enhance therapeutic learning from exposure-based cognitive-behavioral therapy (CBT).
Saturday, 6-Jan-2007 05:29 AM :: Anxiety Insights

Avoid hidden "Forks in the Road" to anxiety, depression
We don't think of a "fork in the road" as an integral part of daily life. Usually it indicates some defining moment of change — the end of a marriage or the beginning of a new career.
Saturday, 6-Jan-2007 05:27 AM :: Anxiety Insights

Abstract: Effects of SSRIs and venlafaxine [Effexor®] during pregnancy in term and preterm neonates
Pediatrics. 2007 Jan;119(1):52-9. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Ferreira E, Carceller AM, Agogue C, Martin BZ, St-Andre M, Francoeur D, Berard A.
Saturday, 6-Jan-2007 05:26 AM :: Anxiety Insights

Abstract: Depression may quadruple stroke risk for under 65s
Emerging evidence raises the possibility of an association between depression and stroke risk. This study sought to examine whether depressive symptoms are associated with an increased risk of cerebrovascular events in a community-based sample.
Saturday, 6-Jan-2007 05:25 AM :: Anxiety Insights

Better poststroke outcome follows antidepressant use
Early detection and appropriate treatment of poststroke depression are essential factors in improving patients' poststroke outcomes.
Saturday, 6-Jan-2007 05:24 AM :: Anxiety Insights

Quetiapine [Seroquel®] addiction?
Quetiapine is not a controlled substance and is not considered addictive. Yet there are several reports describing abuse among inmates in jails and prisons.
Saturday, 6-Jan-2007 05:23 AM :: Anxiety Insights

Hosted by Blog-City v5.0a
Terms & Conditions of this blogcity site